Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy

被引：0
|
作者：
Mariya Asenova Stoynova
Alexander Dimitrov Shinkov
Inna Dimitrova Dimitrova
Inna Angelova Yankova
Roussanka Dimitrova Kovatcheva
机构：
[1] Medical University of Sofia,Department of Endocrinology
[2] University Hospital of Endocrinology,undefined
来源：
International Ophthalmology | 2023年 / 43卷
关键词：
Graves’ orbitopathy; Glucocorticoid regimens; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4747 / 4757
页数：10
相关论文
共 50 条
  • [1] Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves' orbitopathy
    Stoynova, Mariya Asenova
    Shinkov, Alexander Dimitrov
    Dimitrova, Inna Dimitrova
    Yankova, Inna Angelova
    Kovatcheva, Roussanka Dimitrova
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (12) : 4747 - 4757
  • [2] Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy
    Campi, Irene
    Vannucchi, Guia
    Muller, Ilaria
    Lazzaroni, Elisa
    Curro, Nicola
    Dainese, Martina
    Montacchini, Benedetta
    Covelli, Danila
    Guastella, Claudio
    Pignataro, Lorenzo
    Fugazzola, Laura
    Arosio, Maura
    Salvi, Mario
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [3] Role of teprotumumab in the treatment of active moderate-to-severe Graves' orbitopathy
    Bartalena, Luigi
    EUROPEAN THYROID JOURNAL, 2022, 11 (06)
  • [4] Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy
    Lin, Miaoli
    Mao, Yuxiang
    Ai, Siming
    Liu, Guangming
    Zhang, Jian
    Yan, Jianhua
    Yang, Huasheng
    Li, Aimin
    Zou, Yusha
    Liang, Dan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [5] Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy
    Marcocci, Claudio
    Marino, Michele
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 26 (03) : 325 - 337
  • [6] Treatment of moderate-to-severe and active Graves' orbitopathy: a step forward from the OPTIC study
    Tanda, M. L.
    Gallo, D.
    Ippolito, S.
    Bartalena, L.
    Piantanida, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (10) : 1523 - 1525
  • [7] Treatment of moderate-to-severe and active Graves’ orbitopathy: a step forward from the OPTIC study
    M. L. Tanda
    D. Gallo
    S. Ippolito
    L. Bartalena
    E. Piantanida
    Journal of Endocrinological Investigation, 2020, 43 : 1523 - 1525
  • [8] Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?
    Piantanida, E.
    Bartalena, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (08): : 885 - 887
  • [9] Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves’ orbitopathy?
    E. Piantanida
    L. Bartalena
    Journal of Endocrinological Investigation, 2017, 40 : 885 - 887
  • [10] What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
    Bartalena, Luigi
    CLINICAL ENDOCRINOLOGY, 2010, 73 (02) : 149 - 152
12345